TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
PRME

Prime Medicine, Inc.

Healthcare · Biotechnology

3.10$ -1.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRME
Line item 2019 2020 2021 2022 2023 2024 2025
– +529.9% +451.0% +19.4% -46.2% +53.5% +15.2%
– +514.0% +406.7% +9.6% -51.8% +48.2% -14.4%
– +327.6% +401.5% +1.2% -77.8% +338.9% -65.5%
– +516.7% +405.6% +9.0% -58.6% +56.5% -6.7%
– – +2,530.5% +21.2% – – –
– +191.6% +192.3% -29.3% +38.0% +137.5% +53.7%
– +166.0% +198.2% -53.9% +111.2% -32.7% -1.4%
– – -58.1% +59.4% -20.7% -61.0% +125.2%
– – +474.0% +201.9% +351.0% -41.9% -21.7%
– +2,309.9% +615.7% +32.0% -57.9% +15.1% -21.1%
– – – – – – –
– +0.0% +0.0% +1.5% -6.4% +30.4% +25.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?